NCT06562647 2026-02-13
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Phase NA Recruiting
Cell Origin Biotech (Hangzhou) Co., Ltd.
Canada Royal Enoch Phytomedicine Co., Ltd.